Cargando…

Response to Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594

Detalles Bibliográficos
Autores principales:	Ramos-Zavala, Maria G., González-Ortiz, Manuel, Martínez-Abundis, Esperanza, Robles-Cervantes, José A., González-López, Roberto, Santiago-Hernández, Nestor J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Diabetes Care Electronic Pages
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263891/ http://dx.doi.org/10.2337/dc11-2035

Ejemplares similares

Comment on: Ramos-Zavala et al. Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2011;34:1591–1594
por: Tobar, Natália, et al.
Publicado: (2012)

Effect of Diacerein on Insulin Secretion and Metabolic Control in Drug-Naïve Patients With Type 2 Diabetes: A randomized clinical trial
por: Ramos-Zavala, Maria G., et al.
Publicado: (2011)

Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
por: Basevi, Vittorio, et al.
Publicado: (2011)

Response to Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
por: Wysham, Carol H., et al.
Publicado: (2011)

Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: van Hateren, K.J.J., et al.
Publicado: (2011)

Response to Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: Rogers, Mary A.M.
Publicado: (2011)

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Response to Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Ekinci, Elif I., et al.
Publicado: (2011)

Comment on: Chakkera et al. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011;34:2141–2145
por: Valderhaug, Tone Gretland, et al.
Publicado: (2012)

Comment on: Ellervik et al. Elevated Transferrin Saturation and Risk of Diabetes: Three Population-Based Studies. Diabetes Care 2011;34:2256–2258
por: Conway, Baqiyyah N.
Publicado: (2012)

Comment on: Bopp et al. Routine Data Sources Challenge International Diabetes Federation Extrapolations of National Diabetes Prevalence in Switzerland. Diabetes Care 2011;34:2387–2389
por: Unwin, Nigel, et al.
Publicado: (2012)

Response to Comment on: Chakkera et al. Pretransplant Risk Score for New-Onset Diabetes After Kidney Transplantation. Diabetes Care 2011;34:2141–2145
por: Chakkera, Harini A., et al.
Publicado: (2012)

Response to Comment on: Ellervik et al. Elevated Transferrin Saturation and Risk of Diabetes: Three Population-Based Studies. Diabetes Care 2011;34:2256–2258
por: Ellervik, Christina, et al.
Publicado: (2012)

Response to Comment on: Bopp et al. Routine Data Sources Challenge International Diabetes Federation Extrapolations of National Diabetes Prevalence in Switzerland. Diabetes Care 2011;34:2387–2389
por: Bopp, Matthias, et al.
Publicado: (2012)

Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;34:1821–1826
por: Lim, Su Chi, et al.
Publicado: (2011)

Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163
por: Malandrino, Noemi, et al.
Publicado: (2012)

Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163
por: Bakker, Sjoerd F., et al.
Publicado: (2012)

Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Kuhadiya, Nitesh D., et al.
Publicado: (2012)

Response to Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;34:1821–1826
por: Cherney, David Z.I., et al.
Publicado: (2011)

Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Sonmez, Alper, et al.
Publicado: (2011)

Response to Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163
por: Leeds, John S., et al.
Publicado: (2012)

Response to Comment on: Wehr et al. Low Free Testosterone Levels Are Associated With All-Cause and Cardiovascular Mortality in Postmenopausal Diabetic Women. Diabetes Care 2011;34:1771–1777
por: Lerchbaum, Elisabeth, et al.
Publicado: (2012)

Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
por: Blanco, Jesús, et al.
Publicado: (2011)

Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837
por: Jones, T. Hugh, et al.
Publicado: (2011)

Comment on: Hernandez et al. Patterns of Glycemia in Normal Pregnancy: Should the Current Therapeutic Targets Be Challenged? Diabetes Care 2011;34:1660–1668
por: Ryan, Edmond A.
Publicado: (2011)

Comment on: Lipsky et al. Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection. Diabetes Care 2011;34:1695–1700
por: Aragón-Sánchez, Javier, et al.
Publicado: (2011)

Comment on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Barbour, Linda A., et al.
Publicado: (2012)

Comment on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Lau, Sue Mei
Publicado: (2012)

Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
por: McDonald, Tim J., et al.
Publicado: (2011)

Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Rossen, Niklas B., et al.
Publicado: (2011)

Response to Comment on: Hernandez et al. Patterns of Glycemia in Normal Pregnancy: Should the Current Therapeutic Targets Be Challenged? Diabetes Care 2011;34:1660–1668
por: Hernandez, Teri L., et al.
Publicado: (2011)

Response to Comment on: Lipsky et al. Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection. Diabetes Care 2011;34:1695–1700
por: Lipsky, Benjamin A., et al.
Publicado: (2011)

Response to Comments on: Rowan et al. Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU): Body Composition at 2 Years of Age. Diabetes Care 2011;34:2279–2284
por: Rowan, Janet A., et al.
Publicado: (2012)

Comment on: Kromhout et al. n-3 Fatty Acids, Ventricular Arrhythmia–Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients With Diabetes. Diabetes Care 2011;34:2515–2520
por: Giordani, Ilaria, et al.
Publicado: (2012)

Comment on: Hegde et al. Effect of 3-Month Yoga on Oxidative Stress in Type 2 Diabetes With or Without Complications: A Controlled Clinical Trial. Diabetes Care 2011;34: 2208–2210
por: Sperandei, Sandro
Publicado: (2012)

Response to Comment on: Hermida et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes. Diabetes Care 2011;34:1270–1276
por: Hermida, Ramón C., et al.
Publicado: (2011)

Comment on: Gaillard et al. HDL Dysfunctionality (Paraoxonase) Is Worse in Nondiabetic, Postmenopausal African American Than in White Women. Diabetes Care 2011;34:e19
por: Viktorinova, Alena, et al.
Publicado: (2011)

Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
por: Natarajan, Sabareesh, et al.
Publicado: (2012)

Comment on: Olsson et al. High Levels of Education Are Associated With an Increased Risk of Latent Autoimmune Diabetes in Adults: Results From the Nord-Trøndelag Health Study. Diabetes Care 2011;34:102–107
por: Sawicki, Peter T., et al.
Publicado: (2011)

Comment on: Sun et al. Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration: The Joslin 50-Year Medalist Study. Diabetes Care 2011;34:968–974
por: Conway, Baqiyyah N., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gkhgslk9u0nscmjh1rphiq66eg